Tag: Covid

Odisha Candidates In UPSC Civil Services IAS IPS IFS Exam
COVID-19: Issue Regarding Extra Attempt To Appear In Exams Very Complicated, UPSC Tells SC

The counsel appearing for the UPSC told the apex court that he needs to take instructions and place on record all the aspects before any decision is taken on the issue.

  • Monday, 07 March 2022
INDIA Covid19 CASES
India Logs 4,362 New COVID-19 Cases, 66 Fatalities

The active COVID-19 cases in the country has dipped to 54,118 and comprised 0.13 per cent of the total infections, while the national COVID-19 recovery rate has further improved to 98.68 per cent, the ministry said.

  • Monday, 07 March 2022
Mild Symptoms But More Transmissibility, Covid Task Force Member On BA.2
Global Covid Caseload Tops 446.1 Mn

The second worst hit country in terms of cases is India (42,962,953 infections and 515,036 deaths), followed by Brazil (29,056,525 infections and 652,438 deaths).

  • Monday, 07 March 2022
Covovax Receives WHO Approval For Emergency Use
Covid: Govt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults

The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for conducting a phase-3 clinical trial of the single-dose COVID-19 vaccine Sputnik Light as a booster dose.

  • Sunday, 06 March 2022
Over 3 Cr Teenagers Fully Vaccinated Against Covid
Over 3 Cr Teenagers Fully Vaccinated Against Covid

The country has also administered over 2 crore precaution doses among the eligible beneficiaries. Additionally, over 97 per cent of India's adult population has also received their first dose of vaccine against Covid-19.

  • Saturday, 05 March 2022
Over 5 Crore Adolescents Administered First Dose Of Covid Vaccine: Union Health Minister 
Booster Dose: India's Pharma Sector To Grow At 6-8% Yoy In FY23

In a research note, India Ratings and Research (Ind-Ra) said it has maintained a neutral outlook for the Indian pharmaceutical sector for FY23.

  • Saturday, 05 March 2022
India Logs 5,921 New COVID-19 Cases, 289 Deaths
India Logs 5,921 New COVID-19 Cases, 289 Deaths

The active cases comprise 0.17 per cent of the total infections, while the national COVID-19 recovery rate has further improved to 98.65 per cent, the ministry said.

  • Saturday, 05 March 2022
Coronavirus
Global Covid Caseload Tops 443.4 Mn

The second worst hit country in terms of cases is India (42,951,556 infections and 514,589 deaths), followed by Brazil (28,978,052 infections and 651,522 deaths).

  • Saturday, 05 March 2022
Antibody Therapies, Vax Blunted By All Three Omicron Subvariants: Study
Antibody Therapies, Vax Blunted By All Three Omicron Subvariants: Study

Of 19 antibodies, 17 were ineffective against the BA.2 subvariant. The researchers found that bebtelovimab, the latest monoclonal antibody to receive FDA Emergency Use Authorisation, is the only currently available antibody therapy that can adequately treat all three Omicron subvariants.

  • Friday, 04 March 2022
Mahashivratri 2022: Odisha Govt Asks Collectors To Decide On Restrictions
Mahashivratri 2022: Odisha Govt Asks District Collectors To Decide Restrictions

With just two days before Mahashivratri, the Odisha government has issued an important instruction regarding the celebration of the much-awaited festival dedicated to Lord Shiva. 

  • Saturday, 26 February 2022
Covid Testing
Active COVID-19 Cases In India Decline To 2,02,131

A reduction of 22,056 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

  • Monday, 21 February 2022
Covid: UK Monitoring Hybrid Deltacron Strain
Global Covid Caseload Tops 424.1 Mn

The US continues to be the worst-hit country with the world's highest number of cases and deaths at 78,476,869 and 935,331, according to the CSSE.

  • Monday, 21 February 2022
Global Covid Cases
Global Covid Caseload Tops 415.1 Mn

The US continues to be the worst-hit country with the world's highest number of cases and deaths at 78,036,352 and 925,438, according to the CSSE.

  • Wednesday, 16 February 2022
Corbevax Gets Drug Controllers Emergency Use Authorisation
Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age group

Based on the no-objection certificate, Biological E has initiated the clinical study in October 2021 and has evaluated the available safety and immunogenicity results of the ongoing phase 2/3 study, which indicated that the vaccine is safe and immunogenic.

  • Sunday, 13 February 2022
Pfizer To Rake In Record-Breaking Earnings Of Over $100 Bn In Covid Vax & Antiviral Pill
Pfizer To Rake In Record-Breaking Earnings Of Over $100 Bn In Covid Vax & Antiviral Pill

More than half of those earnings will be off of its two Covid products, with the vaccine expected to bring in $32 billion in sales, and Paxlovid expected to earn $22 billion.

  • Wednesday, 09 February 2022
scrollToTop